Articles related to RADIOTHERAPY

The GCIG INTERLACE study has demonstrated a significant improvement in 5-year survival rates in advanced cervical cancer, from 72% to 80%, with the addition of induction chemotherapy to standard-of-care chemoradiation.

The study’s findings suggest that palliative radiotherapy could be a viable option for managing pain in multiple myeloma patients. With a complete response rate of 48% and a partial response rate of 38%, this treatment approach shows promise.

With a complete metabolic response rate of 82.1% after just four cycles of induction, this new regimen could change how we approach treatment for young patients with low risk, relapsed classical Hodgkin lymphoma.

Did you know that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery not only provides the same protection against breast cancer recurrence but also substantially reduces life disruption and financial burden for patients?

Explore how high-dose hyperfractionated thoracic radiotherapy is setting new standards in LS-SCLC treatment.

Discover how SABR is setting a new standard in the treatment of inoperable renal cell carcinoma, offering exceptional cancer control with minimal side effects.